Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

NCT06873100 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Polychondritis

Interventions

DRUG: Upadacitinib
DRUG: corticosteroids and immunosuppressants

Sponsor

Peking University People's Hospital